首页 > 最新文献

Free Radical Biology and Medicine最新文献

英文 中文
Integrative analyses of dicarbonyls and advanced glycation end-products with multiomic profiles across tissue, plasma and stool samples reveal methylglyoxal accumulation in colon cancer 对组织、血浆和粪便样本中二羰基和晚期糖基化终产物的多组学分析揭示了甲基乙二醛在结肠癌中的积累。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-22 DOI: 10.1016/j.freeradbiomed.2026.01.034
Giulio Ferrero , Raffaella Mastrocola , Sonia Tarallo , Barbara Pardini , Jean Scheijen , Marjo van de Waarenburg , Gaetano Gallo , Anastasia Chrysovalantou Chatziioannou , Nivonirina Robinot , Pekka Keski-Rahkonen , Gianmarco Piccinno , Nicola Segata , Elom K. Aglago , David J. Hughes , Mazda Jenab , Casper G. Schalkwijk , Alessio Naccarati
Advanced Glycation Endproducts (AGEs) arise from the reaction of proteins with highly reactive dicarbonyl compounds such as methylglyoxal (MGO), glyoxal (GO) and 3-deoxyglucosone (3-DG), which have been implicated in inflammation and carcinogenesis. How dicarbonyls and AGEs are distributed across tumor tissue and surrogate specimens, and how they relate to systemic metabolism, AGE-related pathways, and alterations in gut microbiota in colon cancer, remains poorly understood.
An integrative multi-specimen analysis of MGO, GO, 3-DG and major AGEs was performed using targeted tandem mass spectrometry in matched tumor tissue, adjacent normal mucosa, plasma, and stool from 26 sporadic colon cancer patients. These measurements were combined with tumor RNA-sequencing, untargeted plasma metabolomics, and stool shotgun metagenomics generated from the same individuals.
A marked accumulation of MGO was observed in tumor tissue when compared with adjacent mucosa, accompanied by higher levels of the MGO-derived AGE Nδ-[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1). Tissue MG-H1 concentrations significantly correlated with corresponding plasma levels. Elevated tumor MGO levels were associated with up-regulation of GLO1 (encoding for the detoxifying enzyme glyoxalase-1), DDOST (coding for the AGE-clearance receptor AGE-R1), and the glycolytic flux marker triose phosphate isomerase (TPI), alongside down-regulation of the AGE-scavenger receptor CD36. These findings suggest a candidate remodeling of dicarbonyl-handling pathways. The MGO/GO ratio in tumors was positively associated with the relative abundances of Fusobacterium nucleatum and Parvimonas micra, two bacterial species related to colorectal carcinogenesis, and with metagenomic signatures of oral-derived taxa colonizing the gut.
This pilot integrative analysis highlighted novel coherent associations among tissue, circulating, and stool levels of MGO-derived AGEs, the expression of AGE-related metabolic pathways, and microbial signatures in colon cancer. If confirmed in larger studies, these candidate molecular and microbial interactions may provide novel insights into the dicarbonyl stress involvement in tumor biology.
晚期糖基化终产物(AGEs)是由蛋白质与高活性二羰基化合物如甲基乙二醛(MGO)、乙二醛(GO)和3-脱氧葡萄糖酮(3-DG)反应产生的,这些化合物与炎症和致癌有关。二羰基和AGEs如何分布在肿瘤组织和替代标本中,以及它们如何与结肠癌的全身代谢、age相关途径和肠道微生物群的改变相关,目前尚不清楚。采用靶向串联质谱法对26例散发性结肠癌患者的匹配肿瘤组织、邻近正常粘膜、血浆和粪便中的MGO、GO、3-DG和主要AGEs进行了综合多标本分析。这些测量结果与来自同一个体的肿瘤rna测序、非靶向血浆代谢组学和粪便霰弹枪宏基因组学相结合。与邻近粘膜相比,肿瘤组织中观察到明显的MGO积累,并伴有MGO衍生的AGE Nδ-[5-氢-5-甲基-4-咪唑隆-2-基]-鸟氨酸(MG-H1)水平升高。组织MG-H1浓度与相应的血浆水平显著相关。升高的肿瘤MGO水平与GLO1(编码解毒酶glyoxalase-1)、DDOST(编码age -清除受体AGE-R1)和糖酵解通量标记磷酸三糖异构酶(TPI)的上调以及age -清除受体CD36的下调有关。这些发现提示了二羰基处理途径的候选重构。肿瘤中的MGO/GO比值与两种与结直肠癌发生有关的细菌——核梭杆菌和微细小单胞菌的相对丰度呈正相关,并且与定植肠道的口腔来源类群的宏基因组特征呈正相关。这项试点综合分析强调了组织、循环和粪便中mgo来源的AGEs水平、age相关代谢途径的表达和结肠癌中微生物特征之间的新关联。如果在更大规模的研究中得到证实,这些候选的分子和微生物相互作用可能为二羰基应激参与肿瘤生物学提供新的见解。
{"title":"Integrative analyses of dicarbonyls and advanced glycation end-products with multiomic profiles across tissue, plasma and stool samples reveal methylglyoxal accumulation in colon cancer","authors":"Giulio Ferrero ,&nbsp;Raffaella Mastrocola ,&nbsp;Sonia Tarallo ,&nbsp;Barbara Pardini ,&nbsp;Jean Scheijen ,&nbsp;Marjo van de Waarenburg ,&nbsp;Gaetano Gallo ,&nbsp;Anastasia Chrysovalantou Chatziioannou ,&nbsp;Nivonirina Robinot ,&nbsp;Pekka Keski-Rahkonen ,&nbsp;Gianmarco Piccinno ,&nbsp;Nicola Segata ,&nbsp;Elom K. Aglago ,&nbsp;David J. Hughes ,&nbsp;Mazda Jenab ,&nbsp;Casper G. Schalkwijk ,&nbsp;Alessio Naccarati","doi":"10.1016/j.freeradbiomed.2026.01.034","DOIUrl":"10.1016/j.freeradbiomed.2026.01.034","url":null,"abstract":"<div><div>Advanced Glycation Endproducts (AGEs) arise from the reaction of proteins with highly reactive dicarbonyl compounds such as methylglyoxal (MGO), glyoxal (GO) and 3-deoxyglucosone (3-DG), which have been implicated in inflammation and carcinogenesis. How dicarbonyls and AGEs are distributed across tumor tissue and surrogate specimens, and how they relate to systemic metabolism, AGE-related pathways, and alterations in gut microbiota in colon cancer, remains poorly understood.</div><div>An integrative multi-specimen analysis of MGO, GO, 3-DG and major AGEs was performed using targeted tandem mass spectrometry in matched tumor tissue, adjacent normal mucosa, plasma, and stool from 26 sporadic colon cancer patients. These measurements were combined with tumor RNA-sequencing, untargeted plasma metabolomics, and stool shotgun metagenomics generated from the same individuals.</div><div>A marked accumulation of MGO was observed in tumor tissue when compared with adjacent mucosa, accompanied by higher levels of the MGO-derived AGE Nδ-[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1). Tissue MG-H1 concentrations significantly correlated with corresponding plasma levels. Elevated tumor MGO levels were associated with up-regulation of <em>GLO1</em> (encoding for the detoxifying enzyme glyoxalase-1), <em>DDOST</em> (coding for the AGE-clearance receptor AGE-R1), and the glycolytic flux marker triose phosphate isomerase (TPI), alongside down-regulation of the AGE-scavenger receptor CD36. These findings suggest a candidate remodeling of dicarbonyl-handling pathways. The MGO/GO ratio in tumors was positively associated with the relative abundances of <em>Fusobacterium nucleatum</em> and <em>Parvimonas micra</em>, two bacterial species related to colorectal carcinogenesis, and with metagenomic signatures of oral-derived taxa colonizing the gut.</div><div>This pilot integrative analysis highlighted novel coherent associations among tissue, circulating, and stool levels of MGO-derived AGEs, the expression of AGE-related metabolic pathways, and microbial signatures in colon cancer. If confirmed in larger studies, these candidate molecular and microbial interactions may provide novel insights into the dicarbonyl stress involvement in tumor biology.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 518-530"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BMAL1 downregulation exacerbates age-related nonalcoholic steatohepatitis by promoting NLRP3 inflammasome activation via HIF-1ɑ-mediated glycolysis BMAL1下调通过HIF-1介导的糖酵解促进NLRP3炎性体激活,加重年龄相关性非酒精性脂肪性肝炎
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-30 DOI: 10.1016/j.freeradbiomed.2026.01.058
Yujie Ren , Dongying Lv , Jiayan Chen , Wenjing Chen , Chu Chen , Lizong Zhang , Jue Tu , Keyan Zhu , Dejun Wang , Zhaowei Cai

Introduction

Epidemiological studies have demonstrated higher incidence and mortality rate of nonalcoholic steatohepatitis (NASH) in the elderly population than in younger groups. However, the mechanisms underlying this age-related exacerbation remain poorly understood.

Objective

This study aimed to elucidate the specific pathways through which aging exacerbates NASH progression, using an integrated in vivo and in vitro model.

Methods

Aged (18-month-old) and young (6-week-old) mice were fed a high-fat diet (HFD) for 16 weeks to induce NASH. A senescence-associated cellular model of NASH was established by co-treating murine hepatocyte AML-12 with H2O2 and free fatty acid (FFA). Gene expression profiling of liver tissue was performed using RNA sequencing to identify molecular signatures. Interventions were as follows: (1) In vitro, BMAL1 overexpression plasmids were transfected into AML-12 cells, followed by treatment with 2-deoxy-D-glucose (2-DG, a glycolysis inhibitor) and 2-methoxyestradiol (2-ME2, a HIF-1α inhibitor); (2) in vivo, hepatocyte-specific BMAL1 overexpression was achieved in aged HFD-fed mice through adeno-associated virus serotype 8 (AAV8) delivery. Mechanism validation was performed using biochemical assays, Western blot, cell staining, molecular docking, and Co-IP.

Results

Aged HFD-fed mice exhibited more severe NASH phenotypes than young mice. Transcriptomic analysis identified NLRP3-related signaling and circadian rhythm pathways as central contributors to age-specific NASH pathogenesis. These mice also exhibited elevated NLRP3 inflammasome activity, enhanced glycolysis, and reduced BMAL1 expression. In senescent NASH cells, BMAL1 overexpression along with 2-DG or 2-ME2 treatment significantly downregulated NLRP3 expression and attenuated lipid accumulation, inflammation, oxidative stress, and fibrosis. Mechanistically, BMAL1 directly bound to HIF-1α, thereby suppressing glycolysis. Hepatocyte-specific BMAL1 overexpression in aged HFD-fed mice markedly inhibited glycolysis and NLRP3 activation, resulting in an improvement in NASH-related pathologies.

Conclusion

This study revealed a novel mechanism in which BMAL1 downregulation under aging and HFD conditions promotes NASH progression by binding to HIF-1α and modulating the glycolysis-NLRP3 inflammasome axis.
流行病学研究表明,老年人非酒精性脂肪性肝炎(NASH)的发病率和死亡率高于年轻人。然而,这种与年龄相关的恶化的机制仍然知之甚少。目的:本研究旨在通过体内和体外综合模型阐明衰老加剧NASH进展的具体途径。方法:老龄小鼠(18月龄)和幼龄小鼠(6周龄)喂食高脂饮食(HFD) 16周,诱导NASH。用H2O2和游离脂肪酸(FFA)共处理小鼠肝细胞AML-12,建立衰老相关的NASH细胞模型。肝组织基因表达谱使用RNA测序来识别分子特征。干预措施如下:(1)体外将BMAL1过表达质粒转染至AML-12细胞,然后用2-脱氧-d -葡萄糖(2-DG,糖酵解抑制剂)和2-甲氧基雌二醇(2-ME2, HIF-1α抑制剂)处理;(2)在体内,通过腺相关病毒血清型8 (AAV8)递送,在老年hmd喂养小鼠中实现了肝细胞特异性BMAL1的过表达。通过生化分析、Western blot、细胞染色、分子对接和Co-IP进行机制验证。结果:老年hfd喂养小鼠比年轻小鼠表现出更严重的NASH表型。转录组学分析确定nlrp3相关信号通路和昼夜节律通路是年龄特异性NASH发病机制的主要因素。这些小鼠还表现出NLRP3炎性体活性升高,糖酵解增强,BMAL1表达降低。在衰老NASH细胞中,BMAL1过表达以及2-DG或2-ME2处理显著下调NLRP3表达,减轻脂质积累、炎症、氧化应激和纤维化。在机制上,BMAL1直接与HIF-1α结合,从而抑制糖酵解。老年hfd喂养小鼠肝细胞特异性BMAL1过表达显著抑制糖酵解和NLRP3激活,导致nash相关病理改善。结论:本研究揭示了衰老和HFD条件下BMAL1下调通过与HIF-1α结合并调节糖酵解- nlrp3炎症小体轴促进NASH进展的新机制。
{"title":"BMAL1 downregulation exacerbates age-related nonalcoholic steatohepatitis by promoting NLRP3 inflammasome activation via HIF-1ɑ-mediated glycolysis","authors":"Yujie Ren ,&nbsp;Dongying Lv ,&nbsp;Jiayan Chen ,&nbsp;Wenjing Chen ,&nbsp;Chu Chen ,&nbsp;Lizong Zhang ,&nbsp;Jue Tu ,&nbsp;Keyan Zhu ,&nbsp;Dejun Wang ,&nbsp;Zhaowei Cai","doi":"10.1016/j.freeradbiomed.2026.01.058","DOIUrl":"10.1016/j.freeradbiomed.2026.01.058","url":null,"abstract":"<div><h3>Introduction</h3><div>Epidemiological studies have demonstrated higher incidence and mortality rate of nonalcoholic steatohepatitis (NASH) in the elderly population than in younger groups. However, the mechanisms underlying this age-related exacerbation remain poorly understood.</div></div><div><h3>Objective</h3><div>This study aimed to elucidate the specific pathways through which aging exacerbates NASH progression, using an integrated <em>in vivo</em> and <em>in vitro</em> model.</div></div><div><h3>Methods</h3><div>Aged (18-month-old) and young (6-week-old) mice were fed a high-fat diet (HFD) for 16 weeks to induce NASH. A senescence-associated cellular model of NASH was established by co-treating murine hepatocyte AML-12 with H<sub>2</sub>O<sub>2</sub> and free fatty acid (FFA). Gene expression profiling of liver tissue was performed using RNA sequencing to identify molecular signatures. Interventions were as follows: (1) <em>In vitro</em>, BMAL1 overexpression plasmids were transfected into AML-12 cells, followed by treatment with 2-deoxy-D-glucose (2-DG, a glycolysis inhibitor) and 2-methoxyestradiol (2-ME2, a HIF-1α inhibitor); (2) <em>in vivo</em>, hepatocyte-specific BMAL1 overexpression was achieved in aged HFD-fed mice through adeno-associated virus serotype 8 (AAV8) delivery. Mechanism validation was performed using biochemical assays, Western blot, cell staining, molecular docking, and Co-IP.</div></div><div><h3>Results</h3><div>Aged HFD-fed mice exhibited more severe NASH phenotypes than young mice. Transcriptomic analysis identified NLRP3-related signaling and circadian rhythm pathways as central contributors to age-specific NASH pathogenesis. These mice also exhibited elevated NLRP3 inflammasome activity, enhanced glycolysis, and reduced BMAL1 expression. In senescent NASH cells, BMAL1 overexpression along with 2-DG or 2-ME2 treatment significantly downregulated NLRP3 expression and attenuated lipid accumulation, inflammation, oxidative stress, and fibrosis. Mechanistically, BMAL1 directly bound to HIF-1α, thereby suppressing glycolysis. Hepatocyte-specific BMAL1 overexpression in aged HFD-fed mice markedly inhibited glycolysis and NLRP3 activation, resulting in an improvement in NASH-related pathologies.</div></div><div><h3>Conclusion</h3><div>This study revealed a novel mechanism in which BMAL1 downregulation under aging and HFD conditions promotes NASH progression by binding to HIF-1α and modulating the glycolysis-NLRP3 inflammasome axis.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 562-579"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic traits and diet triggering the iron-induced hepatic model of the idiopathic disorder sporadic porphyria cutanea tarda 遗传性状和饮食触发特发性散发性迟发性皮肤卟啉症的铁诱导肝脏模型
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-14 DOI: 10.1016/j.freeradbiomed.2025.12.049
Susan Robinson , Reginald Davies , Viktoria Vagany , Timothy W. Gant , Andrew G. Smith
Metabolic disorders can be the consequence of external factors and individual susceptibility. Sporadic porphyria cutanea tarda (sPCT) is an idiopathic disorder of liver heme synthesis exhibiting inhibition of uroporphyrinogen decarboxylase, characterised by dermal and hepatic deposition of uroporphyrins from oxidation of sensitive uroporphyrinogens (uroporphyria). sPCT is associated with alcohol, estrogenic drugs, HIV and hepatitis C, as well as a poorly understood influence of iron. Hexachlorobenzene (HCB) and reputably 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) cause a similar disorder. The hepatic aspects modelled in susceptible rodents in response to HCB and TCDD are potentiated by iron. Importantly, iron overload alone eventually causes hepatic uroporphyria in genetically susceptible mice. To determine whether this genetic susceptibility to iron toxicity is the consequence of a single genetic variant or is multigenic, a low power F2 intercross cross from sensitive SWR and resistant DBA/2 strains was used to detect chromosomal quantitative trait loci (QTL) associated with uroporphyria development enhanced by the heme precursor 5-aminolevulinic acid (5-ALA). Multiple QTL contributed to the development of uroporphyria. Differential gene expressions comparing mice of parent strains and the F2 extremes of resistance and susceptibility suggested possible contributions associated with QTL. Positions of QTL and the confidence regions were compared with those observed previously for uroporphyria induced more rapidly by TCDD in iron-loaded mice and showed overlapping but not identical loci. A difference in uroporphyric response to iron loading occurred with another sensitive strain, C57BL/10ScSn, whether maintained on one of two well-defined, but similar, same source commercial diets. Uroporphyria developed with a nutritionally enhanced diet rather than a lean maintenance diet. One common observation with uroporphyria was decreased expression of Glul for glutamine synthetase. The findings illustrate the interaction of polygenic factors, external factors and diet in models of idiopathic human disorders such as sPCT.
代谢紊乱可能是外部因素和个体易感性的结果。散发性皮肤卟啉症(sPCT)是一种特发性肝血红素合成疾病,表现为尿卟啉原脱羧酶的抑制,其特征是由于敏感的尿卟啉原(尿卟啉症)氧化导致皮肤和肝脏沉积尿卟啉。sPCT与酒精、雌激素药物、艾滋病毒和丙型肝炎以及铁的影响有关。六氯苯(HCB)和著名的2,3,7,8-四氯二苯并对二恶英(TCDD)引起类似的疾病。在易感啮齿类动物中模拟的对HCB和TCDD反应的肝脏方面被铁增强。重要的是,铁超载最终会导致遗传性易感小鼠的肝性尿卟啉症。为了确定这种对铁毒性的遗传易感性是单一遗传变异还是多基因的结果,使用敏感SWR和抗性DBA/2菌株的低功率F2交叉杂交来检测与血红素前体5-氨基乙酰丙酸(5-ALA)增强的尿卟啉症相关的染色体数量性状位点(QTL)。多个QTL对尿卟啉症的发展有促进作用。亲本品系的差异基因表达与耐、易感F2极值的比较提示可能与QTL有关。与先前观察到的TCDD在铁负荷小鼠中更快诱导的尿卟啉症的QTL和置信区域的位置进行比较,发现重叠但不相同的位点。另一种敏感菌株C57BL/10ScSn对铁负荷的尿卟反应存在差异,无论是维持在两种定义明确但相似的来源相同的商业饲料中的一种。尿卟啉症的发展与营养增强的饮食,而不是瘦的维持饮食。尿卟啉症的一个常见观察是谷氨酰胺合成酶gll的表达降低。这些发现说明了多基因因素、外部因素和饮食在特发性人类疾病(如sPCT)模型中的相互作用。
{"title":"Genetic traits and diet triggering the iron-induced hepatic model of the idiopathic disorder sporadic porphyria cutanea tarda","authors":"Susan Robinson ,&nbsp;Reginald Davies ,&nbsp;Viktoria Vagany ,&nbsp;Timothy W. Gant ,&nbsp;Andrew G. Smith","doi":"10.1016/j.freeradbiomed.2025.12.049","DOIUrl":"10.1016/j.freeradbiomed.2025.12.049","url":null,"abstract":"<div><div>Metabolic disorders can be the consequence of external factors and individual susceptibility. Sporadic porphyria cutanea tarda (sPCT) is an idiopathic disorder of liver heme synthesis exhibiting inhibition of uroporphyrinogen decarboxylase, characterised by dermal and hepatic deposition of uroporphyrins from oxidation of sensitive uroporphyrinogens (uroporphyria). sPCT is associated with alcohol, estrogenic drugs, HIV and hepatitis C, as well as a poorly understood influence of iron. Hexachlorobenzene (HCB) and reputably 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) cause a similar disorder. The hepatic aspects modelled in susceptible rodents in response to HCB and TCDD are potentiated by iron. Importantly, iron overload alone eventually causes hepatic uroporphyria in genetically susceptible mice. To determine whether this genetic susceptibility to iron toxicity is the consequence of a single genetic variant or is multigenic, a low power F2 intercross cross from sensitive SWR and resistant DBA/2 strains was used to detect chromosomal quantitative trait loci (QTL) associated with uroporphyria development enhanced by the heme precursor 5-aminolevulinic acid (5-ALA). Multiple QTL contributed to the development of uroporphyria. Differential gene expressions comparing mice of parent strains and the F2 extremes of resistance and susceptibility suggested possible contributions associated with QTL. Positions of QTL and the confidence regions were compared with those observed previously for uroporphyria induced more rapidly by TCDD in iron-loaded mice and showed overlapping but not identical loci. A difference in uroporphyric response to iron loading occurred with another sensitive strain, C57BL/10ScSn, whether maintained on one of two well-defined, but similar, same source commercial diets. Uroporphyria developed with a nutritionally enhanced diet rather than a lean maintenance diet. One common observation with uroporphyria was decreased expression of <em>Glul</em> for glutamine synthetase. The findings illustrate the interaction of polygenic factors, external factors and diet in models of idiopathic human disorders such as sPCT.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 126-139"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct quaternary reaction behavior and stable charge-transfer complex formation in Schistosoma mansoni sulfide:quinone oxidoreductase 曼氏血吸虫硫化物醌氧化还原酶中独特的季反应行为和稳定的电荷转移复合物形成。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-02-02 DOI: 10.1016/j.freeradbiomed.2026.01.063
Augustin Tshibaka Kabongo , Talaam Keith Kiplangat , Yuki Tayama , Acharjee Rajib , Yuichi Matsuo , Linh Manh Ha , Samandram Sushilkumar Singh , Tetsuo Yamashita , Euki Yazaki , Endah Dwi Hartuti , Tetsuro Matsunaga , Tomoaki Ida , Tomoyoshi Nozaki , Takaaki Akaike , Tomoo Shiba , Jun-Ichi Kishikawa , Shinjiro Hamano , Kiyoshi Kita , Daniel Ken Inaoka
Adults of Schistosoma mansoni reside in the mesenteric veins, where they are naturally exposed to high levels of hydrogen sulfide (H2S). S. mansoni and other intestinal parasites have adapted to this sulfide-rich environment, but the evolved mechanisms to metabolize sulfide remain unelucidated. Here we reveal that the putative sulfide:quinone oxidoreductase (SQOR) encoded by S. mansoni is indeed an SQOR, catalyzing the first step of sulfide metabolism. We demonstrated that S. mansoni SQOR (SmSQOR) is expressed in eggs, cercaria and adult stages and localized in the mitochondria. The reaction catalyzed by SmSQOR was investigated using sulfane sulfur probe 4 (SSP4) and shown to require the co-presence of sulfide, quinone, and a sulfur acceptor, indicating a quaternary complex-mediated mechanism. Unlike human and bacterial SQORs, purified SmSQOR could not reduce quinones in the presence of sulfide alone unless sulfite, cyanide, or L-cysteine (but not coenzyme A or glutathione) was provided as the sulfur acceptor. In the presence of these sulfur acceptors, SmSQOR formed a long-lived charge-transfer (CT) complex, a transient electronically coupled association between electron donor and acceptor, as indicated by a broad band around 637–755 nm in the spectrum, which was associated with a partial loss of enzyme activity. Moreover, residues critical for CT complex formation and SQOR catalysis were identified. Using SSP4, we also demonstrated that SQOR was active in S. mansoni adult, egg, and cercaria stages. Taken together, these features suggest that metabolism of sulfide proceeds differently in S. mansoni than in humans.
成年曼氏血吸虫居住在肠系膜静脉中,在那里它们自然暴露于高水平的硫化氢(H2S)。mansoni和其他肠道寄生虫已经适应了这种富含硫化物的环境,但代谢硫化物的进化机制仍不清楚。本文揭示了mansoni编码的硫化物:醌氧化还原酶(SQOR)确实是一个SQOR,催化了硫化物代谢的第一步。我们证实了S. mansoni SQOR (SmSQOR)在卵、尾蚴和成虫阶段表达,并定位于线粒体。利用硫探针4 (SSP4)对SmSQOR催化的反应进行了研究,结果表明,该反应需要硫化物、醌和硫受体共存在,表明了一个季元络合物介导的机制。与人类和细菌sqor不同,纯化的SmSQOR不能在单独存在硫化物的情况下还原醌,除非提供亚硫酸盐、氰化物或l -半胱氨酸(但不包括辅酶A或谷胱甘肽)作为硫受体。在这些硫受体的存在下,SmSQOR形成了一个长寿命的电荷转移(CT)复合物,这是电子供体和受体之间的一种瞬态电子偶联,如光谱中约637-755 nm的宽带所示,这与酶活性的部分丧失有关。此外,还鉴定了对CT复合物形成和SQOR催化至关重要的残基。利用SSP4,我们还证明SQOR在曼氏血吸虫成虫、卵和尾蚴期都有活性。综上所述,这些特征表明,硫化物的代谢过程在曼氏血吸虫中与在人类中不同。
{"title":"Distinct quaternary reaction behavior and stable charge-transfer complex formation in Schistosoma mansoni sulfide:quinone oxidoreductase","authors":"Augustin Tshibaka Kabongo ,&nbsp;Talaam Keith Kiplangat ,&nbsp;Yuki Tayama ,&nbsp;Acharjee Rajib ,&nbsp;Yuichi Matsuo ,&nbsp;Linh Manh Ha ,&nbsp;Samandram Sushilkumar Singh ,&nbsp;Tetsuo Yamashita ,&nbsp;Euki Yazaki ,&nbsp;Endah Dwi Hartuti ,&nbsp;Tetsuro Matsunaga ,&nbsp;Tomoaki Ida ,&nbsp;Tomoyoshi Nozaki ,&nbsp;Takaaki Akaike ,&nbsp;Tomoo Shiba ,&nbsp;Jun-Ichi Kishikawa ,&nbsp;Shinjiro Hamano ,&nbsp;Kiyoshi Kita ,&nbsp;Daniel Ken Inaoka","doi":"10.1016/j.freeradbiomed.2026.01.063","DOIUrl":"10.1016/j.freeradbiomed.2026.01.063","url":null,"abstract":"<div><div>Adults of <em>Schistosoma mansoni</em> reside in the mesenteric veins, where they are naturally exposed to high levels of hydrogen sulfide (H<sub>2</sub>S). <em>S. mansoni</em> and other intestinal parasites have adapted to this sulfide-rich environment, but the evolved mechanisms to metabolize sulfide remain unelucidated. Here we reveal that the putative sulfide:quinone oxidoreductase (SQOR) encoded by <em>S. mansoni</em> is indeed an SQOR, catalyzing the first step of sulfide metabolism. We demonstrated that <em>S. mansoni</em> SQOR (SmSQOR) is expressed in eggs, cercaria and adult stages and localized in the mitochondria. The reaction catalyzed by SmSQOR was investigated using sulfane sulfur probe 4 (SSP4) and shown to require the co-presence of sulfide, quinone, and a sulfur acceptor, indicating a quaternary complex-mediated mechanism. Unlike human and bacterial SQORs, purified SmSQOR could not reduce quinones in the presence of sulfide alone unless sulfite, cyanide, or L-cysteine (but not coenzyme A or glutathione) was provided as the sulfur acceptor. In the presence of these sulfur acceptors, SmSQOR formed a long-lived charge-transfer (CT) complex, a transient electronically coupled association between electron donor and acceptor, as indicated by a broad band around 637–755 nm in the spectrum, which was associated with a partial loss of enzyme activity. Moreover, residues critical for CT complex formation and SQOR catalysis were identified. Using SSP4, we also demonstrated that SQOR was active in <em>S. mansoni</em> adult, egg, and cercaria stages. Taken together, these features suggest that metabolism of sulfide proceeds differently in <em>S. mansoni</em> than in humans.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 646-659"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interplay between the thioredoxin system and hypoxia-related factors in cancer. 硫氧还蛋白系统与癌症中缺氧相关因素的相互作用。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 DOI: 10.1016/j.freeradbiomed.2026.03.040
Isabella Bramatti, Vasco Branco, Cristina Carvalho

Hypoxia constitutes a common feature of tumor microenvironments, orchestrating cancer progression across various malignancies. Cancer growth and resistance to therapy are frequently associated with overexpression of antioxidant systems, such as the thioredoxin (Trx) system. This system is fundamental for cell survival and proliferation, playing a key role in maintaining redox homeostasis and regulating hypoxia-inducible factor-1alpha (HIF-1α) activity. This, in turn, regulates different genes involved in tumor progression, such as the vascular endothelial growth factor (VEGF), an indispensable factor for tumor invasiveness and microenvironment tumor maintenance. HIF-1α can also be regulated by the signal transducer and activator of transcription 3 (STAT3), an oncogene stimulated by pro-inflammatory cytokines and growth factors. Targeting antioxidant systems, such as the Trx system, is an emerging strategy in cancer therapy, as tumor cells are more vulnerable to disruptions in redox homeostasis than normal cells. Even though there are some studies correlating the use of Trx inhibitors and the inhibition of hypoxia-related factors, the diverse pathways in which this occurs are still elusive. Therefore, in this review, we explore the multiple pathways through which the Trx system influences HIF-1α and highlight drugs that have been studied targeting hypoxia-related factors by inhibiting the Trx system. Given the link between oxidative stress and apoptosis in cancer cells, and the low overall survival rates for many cancers despite new therapies, understanding the Trx system's connection to hypoxia-related pathways could be crucial for advancing therapeutic approaches and tackling therapy resistance.

缺氧是肿瘤微环境的共同特征,在各种恶性肿瘤中协调肿瘤的进展。癌症的生长和对治疗的抵抗通常与抗氧化系统的过度表达有关,如硫氧还蛋白(Trx)系统。该系统是细胞存活和增殖的基础,在维持氧化还原稳态和调节缺氧诱导因子-1α (HIF-1α)活性方面发挥关键作用。这反过来又调节了参与肿瘤进展的不同基因,如血管内皮生长因子(VEGF),这是肿瘤侵袭和微环境肿瘤维持不可或缺的因素。HIF-1α还可受信号转导因子和转录激活因子3 (STAT3)的调控,STAT3是一种受促炎细胞因子和生长因子刺激的致癌基因。靶向抗氧化系统,如Trx系统,是一种新兴的癌症治疗策略,因为肿瘤细胞比正常细胞更容易受到氧化还原稳态的破坏。尽管有一些研究将Trx抑制剂的使用与缺氧相关因子的抑制联系起来,但其发生的多种途径仍然难以捉摸。因此,在这篇综述中,我们探索了Trx系统影响HIF-1α的多种途径,并重点介绍了通过抑制Trx系统靶向缺氧相关因子的药物。考虑到氧化应激和癌细胞凋亡之间的联系,以及尽管有新的治疗方法,许多癌症的总存活率很低,了解Trx系统与缺氧相关途径的联系对于推进治疗方法和解决治疗耐药性至关重要。
{"title":"The interplay between the thioredoxin system and hypoxia-related factors in cancer.","authors":"Isabella Bramatti, Vasco Branco, Cristina Carvalho","doi":"10.1016/j.freeradbiomed.2026.03.040","DOIUrl":"10.1016/j.freeradbiomed.2026.03.040","url":null,"abstract":"<p><p>Hypoxia constitutes a common feature of tumor microenvironments, orchestrating cancer progression across various malignancies. Cancer growth and resistance to therapy are frequently associated with overexpression of antioxidant systems, such as the thioredoxin (Trx) system. This system is fundamental for cell survival and proliferation, playing a key role in maintaining redox homeostasis and regulating hypoxia-inducible factor-1alpha (HIF-1α) activity. This, in turn, regulates different genes involved in tumor progression, such as the vascular endothelial growth factor (VEGF), an indispensable factor for tumor invasiveness and microenvironment tumor maintenance. HIF-1α can also be regulated by the signal transducer and activator of transcription 3 (STAT3), an oncogene stimulated by pro-inflammatory cytokines and growth factors. Targeting antioxidant systems, such as the Trx system, is an emerging strategy in cancer therapy, as tumor cells are more vulnerable to disruptions in redox homeostasis than normal cells. Even though there are some studies correlating the use of Trx inhibitors and the inhibition of hypoxia-related factors, the diverse pathways in which this occurs are still elusive. Therefore, in this review, we explore the multiple pathways through which the Trx system influences HIF-1α and highlight drugs that have been studied targeting hypoxia-related factors by inhibiting the Trx system. Given the link between oxidative stress and apoptosis in cancer cells, and the low overall survival rates for many cancers despite new therapies, understanding the Trx system's connection to hypoxia-related pathways could be crucial for advancing therapeutic approaches and tackling therapy resistance.</p>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":" ","pages":"563-576"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147480202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-surgical periodontal treatment improves mitochondrial bioenergetics in circulating immune cells of patients with chronic periodontitis 非手术牙周治疗可改善慢性牙周炎患者循环免疫细胞的线粒体生物能量。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-09 DOI: 10.1016/j.freeradbiomed.2026.01.010
Jonathan Hermenejildo , María Pelechá-Salvador , Meylin Fernández-Reyes , Laura Perea-Galera , Jordi Mota-Plaza , Javier Silvestre-Rangil , Celia Bañuls , Carlos Morillas , Francisco Javier Silvestre , Víctor M. Víctor , Sandra López-Domènech , Milagros Rocha

Introduction

Chronic periodontitis (CP) is an inflammatory disease associated with local and systemic oxidative stress and leads to mitochondrial homeostasis disruption. Although non-surgical periodontal therapy (NSPT) has been proved to reduce the bacterial load and inflammation, the mechanisms underlying its effects on mitochondrial function and systemic redox balance remain poorly understood.

Methods

Eighty patients with CP underwent NSPT. Clinical, anthropometric, and biochemical parameters were evaluated at baseline and 12 weeks after therapy. Mitochondrial redox status, membrane potential, markers of mitochondrial biogenic signalling (PGC-1α), electron transport chain (ETC) complexes, and bioenergetic function were assessed in peripheral blood mononuclear cells (PBMCs). Correlation and multivariable analyses were performed to explore relationships between periodontal improvement and mitochondrial parameters.

Results

After NSPT, patients presented significant reductions in mitochondrial ROS and increased GPX1 expression. PBMCs also showed elevated PGC-1α and ETC I–IV protein levels, together with enhanced mitochondrial membrane potential, mass, and spare respiratory capacity. Baseline mitochondrial parameters were associated with the percentage of reduction of periodontal clinical parameters following NSPT.

Conclusions

NSPT not only ameliorates local periodontal inflammation but also modulates mitochondrial-related homeostasis and bioenergetic efficiency in circulating immune cells. The present findings support mitochondrial remodelling as a systemic mechanism underlying the benefits of periodontal therapy and a promising target for the treatment of inflammation-related comorbidities.
慢性牙周炎(CP)是一种与局部和全身氧化应激相关的炎症性疾病,可导致线粒体稳态破坏。尽管非手术牙周治疗(NSPT)已被证明可以减少细菌负荷和炎症,但其对线粒体功能和全身氧化还原平衡的影响机制尚不清楚。方法:80例CP患者行NSPT治疗。在基线和治疗后12周评估临床、人体测量和生化参数。研究了外周血单核细胞(PBMCs)线粒体氧化还原状态、膜电位、线粒体生物信号标志物(PGC-1α)、电子传递链(ETC)复合物和生物能量功能。进行相关分析和多变量分析,探讨牙周改善与线粒体参数之间的关系。结果:NSPT后,患者线粒体ROS明显减少,GPX1表达增加。pbmc还显示PGC-1α和ETC I-IV蛋白水平升高,线粒体膜电位、质量和备用呼吸能力增强。基线线粒体参数与NSPT后牙周临床参数降低的百分比相关。结论:NSPT不仅可以改善局部牙周炎症,还可以调节循环免疫细胞中线粒体相关的稳态和生物能量效率。目前的研究结果支持线粒体重塑是牙周治疗益处的一种系统机制,也是治疗炎症相关合并症的一个有希望的靶点。
{"title":"Non-surgical periodontal treatment improves mitochondrial bioenergetics in circulating immune cells of patients with chronic periodontitis","authors":"Jonathan Hermenejildo ,&nbsp;María Pelechá-Salvador ,&nbsp;Meylin Fernández-Reyes ,&nbsp;Laura Perea-Galera ,&nbsp;Jordi Mota-Plaza ,&nbsp;Javier Silvestre-Rangil ,&nbsp;Celia Bañuls ,&nbsp;Carlos Morillas ,&nbsp;Francisco Javier Silvestre ,&nbsp;Víctor M. Víctor ,&nbsp;Sandra López-Domènech ,&nbsp;Milagros Rocha","doi":"10.1016/j.freeradbiomed.2026.01.010","DOIUrl":"10.1016/j.freeradbiomed.2026.01.010","url":null,"abstract":"<div><h3>Introduction</h3><div>Chronic periodontitis (CP) is an inflammatory disease associated with local and systemic oxidative stress and leads to mitochondrial homeostasis disruption. Although non-surgical periodontal therapy (NSPT) has been proved to reduce the bacterial load and inflammation, the mechanisms underlying its effects on mitochondrial function and systemic redox balance remain poorly understood.</div></div><div><h3>Methods</h3><div>Eighty patients with CP underwent NSPT. Clinical, anthropometric, and biochemical parameters were evaluated at baseline and 12 weeks after therapy. Mitochondrial redox status, membrane potential, markers of mitochondrial biogenic signalling (PGC-1α), electron transport chain (ETC) complexes, and bioenergetic function were assessed in peripheral blood mononuclear cells (PBMCs). Correlation and multivariable analyses were performed to explore relationships between periodontal improvement and mitochondrial parameters.</div></div><div><h3>Results</h3><div>After NSPT, patients presented significant reductions in mitochondrial ROS and increased GPX1 expression. PBMCs also showed elevated PGC-1α and ETC I–IV protein levels, together with enhanced mitochondrial membrane potential, mass, and spare respiratory capacity. Baseline mitochondrial parameters were associated with the percentage of reduction of periodontal clinical parameters following NSPT.</div></div><div><h3>Conclusions</h3><div>NSPT not only ameliorates local periodontal inflammation but also modulates mitochondrial-related homeostasis and bioenergetic efficiency in circulating immune cells. The present findings support mitochondrial remodelling as a systemic mechanism underlying the benefits of periodontal therapy and a promising target for the treatment of inflammation-related comorbidities.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 159-168"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketogenic diet improves cognitive impairment in rats with temporal lobe epilepsy by activating the Nrf2/HO-1/GPX4 signaling axis to inhibit ferroptosis 生酮饮食通过激活Nrf2/HO-1/GPX4信号轴抑制铁下垂,改善颞叶癫痫大鼠认知功能障碍
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-21 DOI: 10.1016/j.freeradbiomed.2026.01.022
Lin Yang , Jinlian Wang , Xuhui Wang , Bianli Li , Di Zhao , Chunyi Li , Changzhi Li , Yuanbing Cui , Qiuyuan Chen , Yong Yang , Jinhai Gu , Shaozhang Hou , Lianxiang Zhang , Yuanyuan Qiang
A ketogenic diet (KD) has demonstrated significant therapeutic efficacy in drug-resistant epilepsy. The molecular mechanisms through which KDs exert therapeutic effects on temporal lobe epilepsy (TLE) are not yet fully understood. Recent studies suggest that ferroptosis, a cell death pathway driven by iron-dependent lipid peroxidation, plays a role in the pathophysiological progression of epilepsy. This research revealed that lithium-pilocarpine (LI-PILO)-induced status epilepticus in TLE models triggered pronounced ferroptosis in the rat hippocampus and that KDs inhibited neuronal ferroptosis in the hippocampus, as evidenced by elevated levels of the antioxidant factors, glutathione (GSH) and catalase (CAT), and decreased levels of 4-HNE, Fe2+ and the lipid peroxidation product malondialdehyde (MDA). We also observed ferroptosis-related mitochondrial abnormalities, including reduced mitochondrial volume, disrupted cristae, and the outright disappearance of cristae, in the epilepsy model group. These morphological alterations were markedly attenuated following KD intervention. Furthermore, KDs alleviated both neuronal loss and cognitive impairment in TLE rats. However, the neuroprotective effects of KDs were completely abolished by the ferroptosis inducer erastin. In addition, treatment with the ferroptosis inhibitor ferrostatin-1 (Fer-1) not only reduced hippocampal neuronal damage, as confirmed by Nissl staining and immunofluorescence but also improved cognitive performance in TLE rats, as evidenced by better outcomes in the Morris water maze and novel object recognition tests. With respect to the underlying mechanism, multiomics analysis revealed that KDs alter circulating metabolite profiles. Notably, we revealed that deoxycholyl-L-dopa may be a key metabolite for targeting Keap1, xCT and HO-1. Western blot and qPCR results revealed that KDs activated the Nrf2/HO-1/GPX4 signaling axis and upregulated the expressions of Nrf2, HO-1, FTH1, xCT and GPX4. Our findings identify ferroptosis inhibition as a mechanism underlying the efficacy of KDs in epilepsy.
生酮饮食(KD)已被证明对耐药癫痫有显著的治疗效果。KDs治疗颞叶癫痫的分子机制尚不完全清楚。最近的研究表明,铁下垂是一种由铁依赖性脂质过氧化驱动的细胞死亡途径,在癫痫的病理生理进展中起作用。本研究发现,锂-匹罗卡品(LI-PILO)诱导的TLE模型癫痫持续状态引发大鼠海马明显的铁下垂,KDs抑制海马神经元铁下垂,其表现为抗氧化因子、谷胱甘肽(GSH)和过氧化氢酶(CAT)水平升高,4-HNE、Fe2+和脂质过氧化产物丙二醛(MDA)水平降低。在癫痫模型组中,我们还观察到与铁中毒相关的线粒体异常,包括线粒体体积减少、嵴断裂和嵴完全消失。KD干预后,这些形态学改变明显减弱。此外,KDs还能减轻TLE大鼠的神经元损失和认知功能障碍。然而,KDs的神经保护作用被铁下垂诱导剂erastin完全消除。此外,通过尼氏染色和免疫荧光证实,使用上吊铁抑制剂铁抑素-1 (ferl -1)治疗不仅减轻了海马神经元损伤,而且还改善了TLE大鼠的认知能力,这一点在Morris水迷宫和新型物体识别测试中得到了更好的结果。关于潜在的机制,多组学分析显示,KDs改变了循环代谢物谱。值得注意的是,我们发现脱氧胆碱-左旋多巴可能是靶向Keap1、xCT和HO-1的关键代谢物。Western blot和qPCR结果显示,KDs激活Nrf2/HO-1/GPX4信号轴,上调Nrf2、HO-1、FTH1、xCT和GPX4的表达。我们的研究结果表明,铁下垂抑制是KDs治疗癫痫疗效的一种机制。
{"title":"Ketogenic diet improves cognitive impairment in rats with temporal lobe epilepsy by activating the Nrf2/HO-1/GPX4 signaling axis to inhibit ferroptosis","authors":"Lin Yang ,&nbsp;Jinlian Wang ,&nbsp;Xuhui Wang ,&nbsp;Bianli Li ,&nbsp;Di Zhao ,&nbsp;Chunyi Li ,&nbsp;Changzhi Li ,&nbsp;Yuanbing Cui ,&nbsp;Qiuyuan Chen ,&nbsp;Yong Yang ,&nbsp;Jinhai Gu ,&nbsp;Shaozhang Hou ,&nbsp;Lianxiang Zhang ,&nbsp;Yuanyuan Qiang","doi":"10.1016/j.freeradbiomed.2026.01.022","DOIUrl":"10.1016/j.freeradbiomed.2026.01.022","url":null,"abstract":"<div><div>A ketogenic diet (KD) has demonstrated significant therapeutic efficacy in drug-resistant epilepsy. The molecular mechanisms through which KDs exert therapeutic effects on temporal lobe epilepsy (TLE) are not yet fully understood. Recent studies suggest that ferroptosis, a cell death pathway driven by iron-dependent lipid peroxidation, plays a role in the pathophysiological progression of epilepsy. This research revealed that lithium-pilocarpine (LI-PILO)-induced status epilepticus in TLE models triggered pronounced ferroptosis in the rat hippocampus and that KDs inhibited neuronal ferroptosis in the hippocampus, as evidenced by elevated levels of the antioxidant factors, glutathione (GSH) and catalase (CAT), and decreased levels of 4-HNE, Fe<sup>2+</sup> and the lipid peroxidation product malondialdehyde (MDA). We also observed ferroptosis-related mitochondrial abnormalities, including reduced mitochondrial volume, disrupted cristae, and the outright disappearance of cristae, in the epilepsy model group. These morphological alterations were markedly attenuated following KD intervention. Furthermore, KDs alleviated both neuronal loss and cognitive impairment in TLE rats. However, the neuroprotective effects of KDs were completely abolished by the ferroptosis inducer erastin. In addition, treatment with the ferroptosis inhibitor ferrostatin-1 (Fer-1) not only reduced hippocampal neuronal damage, as confirmed by Nissl staining and immunofluorescence but also improved cognitive performance in TLE rats, as evidenced by better outcomes in the Morris water maze and novel object recognition tests. With respect to the underlying mechanism, multiomics analysis revealed that KDs alter circulating metabolite profiles. Notably, we revealed that deoxycholyl-L-dopa may be a key metabolite for targeting Keap1, xCT and HO-1. Western blot and qPCR results revealed that KDs activated the Nrf2/HO-1/GPX4 signaling axis and upregulated the expressions of Nrf2, HO-1, FTH1, xCT and GPX4. Our findings identify ferroptosis inhibition as a mechanism underlying the efficacy of KDs in epilepsy.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 223-238"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146024670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NRF2 at the crossroads of Parkinson’s disease and aging: Mechanistic insights and translational perspectives 在帕金森病和衰老的十字路口Nrf2:机制的见解和翻译的观点。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-13 DOI: 10.1016/j.freeradbiomed.2026.01.023
A.J. García-Yagüe , N Esteras , A.T. Dinkova-Kostova , A.I. Rojo , P.G. Shiels , A Dinnyes , V Tamas , H. van Goor , I. Lastres-Becker
Parkinson's disease (PD) is a multifactorial neurodegenerative disorder characterized by dopaminergic neuronal loss, α-SYNUCLEIN aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation. The transcription factor NRF2 (nuclear factor erythroid 2–related factor 2) orchestrates cellular defense mechanisms by controlling genes involved in antioxidant responses, detoxification, and proteostasis. Impaired NRF2 signaling in PD amplifies oxidative damage, protein misfolding, and inflammatory cascades, whereas NRF2 activation confers broad neuroprotection. This review summarizes evidence from cellular, animal, and human studies delineating NRF2 regulatory roles in redox homeostasis, mitochondrial integrity, and microglial activation. In preclinical models, NRF2 deficiency accelerates neurodegeneration, while pharmacological activation with agents such as dimethyl fumarate, sulforaphane, and synthetic triterpenoids mitigates dopaminergic loss and neuroinflammation. Human studies reveal altered NRF2 pathway components in PD brain and peripheral tissues, and genetic variants in NFE2L2 influence disease susceptibility and progression. Aging, PD's strongest risk factor, reduces NRF2 responsiveness through epigenetic and post-translational changes, promoting oxidative vulnerability and inflammaging. Environmental exposures, including pesticides and pollutants, further modulate NRF2 activity, compounding risk via cumulative “exposome” effects. Understanding NRF2 regulation provides mechanistic insight into PD pathogenesis and positions NRF2 activation as a promising therapeutic strategy for disease modification and healthy brain aging.
帕金森病(PD)是一种多因素神经退行性疾病,以多巴胺能神经元丧失、α-SYNUCLEIN聚集、线粒体功能障碍、氧化应激和神经炎症为特征。转录因子NRF2(核因子红系2相关因子2)通过控制参与抗氧化反应、解毒和蛋白平衡的基因来协调细胞防御机制。PD中受损的NRF2信号会放大氧化损伤、蛋白质错误折叠和炎症级联反应,而NRF2激活则能提供广泛的神经保护。这篇综述总结了来自细胞、动物和人类研究的证据,描述了NRF2在氧化还原稳态、线粒体完整性和小胶质细胞激活中的调节作用。在临床前模型中,NRF2缺乏加速神经退行性变,而富马酸二甲酯、萝卜硫素和合成三萜等药物的药理激活可减轻多巴胺能损失和神经炎症。人类研究表明,PD脑和外周组织中NRF2通路成分的改变,以及NFE2L2的遗传变异影响疾病的易感性和进展。衰老是帕金森病最强的危险因素,它通过表观遗传和翻译后变化降低NRF2反应性,促进氧化易感性和炎症。环境暴露,包括杀虫剂和污染物,进一步调节NRF2的活性,通过累积的“暴露”效应增加风险。了解NRF2的调控有助于深入了解帕金森病的发病机制,并将NRF2激活作为一种有希望的疾病改变和健康大脑衰老的治疗策略。
{"title":"NRF2 at the crossroads of Parkinson’s disease and aging: Mechanistic insights and translational perspectives","authors":"A.J. García-Yagüe ,&nbsp;N Esteras ,&nbsp;A.T. Dinkova-Kostova ,&nbsp;A.I. Rojo ,&nbsp;P.G. Shiels ,&nbsp;A Dinnyes ,&nbsp;V Tamas ,&nbsp;H. van Goor ,&nbsp;I. Lastres-Becker","doi":"10.1016/j.freeradbiomed.2026.01.023","DOIUrl":"10.1016/j.freeradbiomed.2026.01.023","url":null,"abstract":"<div><div>Parkinson's disease (PD) is a multifactorial neurodegenerative disorder characterized by dopaminergic neuronal loss, α-SYNUCLEIN aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation. The transcription factor NRF2 (nuclear factor erythroid 2–related factor 2) orchestrates cellular defense mechanisms by controlling genes involved in antioxidant responses, detoxification, and proteostasis. Impaired NRF2 signaling in PD amplifies oxidative damage, protein misfolding, and inflammatory cascades, whereas NRF2 activation confers broad neuroprotection. This review summarizes evidence from cellular, animal, and human studies delineating NRF2 regulatory roles in redox homeostasis, mitochondrial integrity, and microglial activation. In preclinical models, NRF2 deficiency accelerates neurodegeneration, while pharmacological activation with agents such as dimethyl fumarate, sulforaphane, and synthetic triterpenoids mitigates dopaminergic loss and neuroinflammation. Human studies reveal altered NRF2 pathway components in PD brain and peripheral tissues, and genetic variants in <em>NFE2L2</em> influence disease susceptibility and progression. Aging, PD's strongest risk factor, reduces NRF2 responsiveness through epigenetic and post-translational changes, promoting oxidative vulnerability and inflammaging. Environmental exposures, including pesticides and pollutants, further modulate NRF2 activity, compounding risk via cumulative “exposome” effects. Understanding NRF2 regulation provides mechanistic insight into PD pathogenesis and positions NRF2 activation as a promising therapeutic strategy for disease modification and healthy brain aging.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 760-779"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin-like growth factor 2 mRNA-binding Protein 2 regulates PINK1 expression through m6A pathway to promote mitophagy in BMSCs alleviating postmenopausal osteoporosis 胰岛素样生长因子2 mrna结合蛋白2通过m6A通路调控PINK1表达促进骨髓间充质干细胞自噬,缓解绝经后骨质疏松
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-23 DOI: 10.1016/j.freeradbiomed.2026.01.038
Yu Ji , Yajun Cui , Lingshuang Li , Tianyu Cao , Hongrui Liu , Minqi Li
The senescence and altered differentiation potential of bone marrow mesenchymal stem cells (BMSCs) contribute to the pathogenesis of postmenopausal osteoporosis (PMOP). Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) has been demonstrated to regulate BMSCs. However, its specific mechanistic actions remain unclear, particularly due to the lack of concrete evidence within the ovariectomy (OVX) in vivo microenvironment. In this study, we utilized Cre-LoxP technology to achieve BMSC-specific IMP2 knockout. This approach conclusively demonstrated in vivo that IMP2 deficiency induces BMSC senescence, suppresses osteogenic differentiation capacity, and leads to significant bone mass reduction in mice. Under OVX condition, IMP2 knockout also aggravates bone loss. Mechanistically, we argued that IMP2 stabilizes PINK1 mRNA via the N6-methyladenosine (m6A) pathway; upon IMP2 silencing, reduced PINK1 protein expression attenuates mitophagy in BMSCs, ultimately culminating in accelerated cellular senescence and diminished osteogenic potential, with the postmenopausal environment further aggravating this cascade.
骨髓间充质干细胞(BMSCs)的衰老和分化潜能的改变与绝经后骨质疏松症(PMOP)的发病机制有关。胰岛素样生长因子2 mrna结合蛋白(IMP2)已被证实可调节骨髓间充质干细胞。然而,其具体的机制作用尚不清楚,特别是由于缺乏卵巢切除术(OVX)体内微环境的具体证据。在本研究中,我们利用Cre-LoxP技术实现了bmsc特异性的IMP2敲除。该方法在体内最终证明,IMP2缺乏诱导BMSC衰老,抑制成骨分化能力,导致小鼠骨量显著减少。在OVX条件下,IMP2敲除也会加重骨质流失。在机制上,我们认为IMP2通过n6 -甲基腺苷(m6A)途径稳定PINK1 mRNA;IMP2沉默后,PINK1蛋白表达的减少会减弱骨髓间充质干细胞的自噬,最终导致细胞衰老加速和成骨潜能减弱,绝经后的环境进一步加剧了这一级联反应。
{"title":"Insulin-like growth factor 2 mRNA-binding Protein 2 regulates PINK1 expression through m6A pathway to promote mitophagy in BMSCs alleviating postmenopausal osteoporosis","authors":"Yu Ji ,&nbsp;Yajun Cui ,&nbsp;Lingshuang Li ,&nbsp;Tianyu Cao ,&nbsp;Hongrui Liu ,&nbsp;Minqi Li","doi":"10.1016/j.freeradbiomed.2026.01.038","DOIUrl":"10.1016/j.freeradbiomed.2026.01.038","url":null,"abstract":"<div><div>The senescence and altered differentiation potential of bone marrow mesenchymal stem cells (BMSCs) contribute to the pathogenesis of postmenopausal osteoporosis (PMOP). Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) has been demonstrated to regulate BMSCs. However, its specific mechanistic actions remain unclear, particularly due to the lack of concrete evidence within the ovariectomy (OVX) <em>in vivo</em> microenvironment. In this study, we utilized Cre-LoxP technology to achieve BMSC-specific IMP2 knockout. This approach conclusively demonstrated <em>in vivo</em> that IMP2 deficiency induces BMSC senescence, suppresses osteogenic differentiation capacity, and leads to significant bone mass reduction in mice. Under OVX condition, IMP2 knockout also aggravates bone loss. Mechanistically, we argued that IMP2 stabilizes PINK1 mRNA via the N6-methyladenosine (m<sup>6</sup>A) pathway; upon IMP2 silencing, reduced PINK1 protein expression attenuates mitophagy in BMSCs, ultimately culminating in accelerated cellular senescence and diminished osteogenic potential, with the postmenopausal environment further aggravating this cascade.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 400-414"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIF-1α translation mediated by PKCδ facilitates RSV-induced production of innate inflammatory cytokines in vitro and in vivo 在体外和体内,PKCδ介导的HIF-1α翻译促进rsv诱导的先天炎症因子的产生。
IF 8.2 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-03-16 Epub Date: 2026-01-27 DOI: 10.1016/j.freeradbiomed.2026.01.049
Lifeng Chen , Jiayi Chen , Chuyi Liao , Bin Chen , Jiahua Zou , Yujun Tang , Si Xiong , Zhong Liu , Manmei Li
A cytokine storm caused by respiratory syncytial virus (RSV) significantly influences the progression of pneumonia and bronchiolitis. It is essential to comprehend the underlying mechanism of the RSV-triggered cytokine storm to effectively manage RSV. Hypoxia-inducible factor-1 Alpha (HIF-1α) plays a pivotal role in innate immunity. It is known that RSV enhances HIF-1α expression, but the molecular mechanism of RSV-induced HIF-1α expression and its role in the production of innate inflammatory cytokines during RSV infection are not fully understood. Our research demonstrates that RSV infection increases HIF-1α expression both in vitro and in vivo. Further investigation into the mechanism of RSV-induced HIF-1α expression indicates that PKCδ regulates RSV-induced HIF-1α translation through the PI3K/Akt/mTOR signaling pathway. Additionally, HIF-1α expression, mediated by PKCδ/PI3K/Akt/mTOR signaling, stimulates the production of innate inflammatory cytokines by activating the NLRP3-inflammasome during RSV infection. Inhibition of HIF-1α or PKCδ markedly suppresses RSV-induced inflammation in vitro and in vivo. In summary, these findings elucidate the molecular mechanism of RSV-induced HIF-1α expression and identify HIF-1α as a novel target for anti-RSV drug development.
呼吸道合胞病毒(RSV)引起的细胞因子风暴显著影响肺炎和细支气管炎的进展。了解RSV引发的细胞因子风暴的潜在机制对于有效地控制RSV至关重要。缺氧诱导因子-1α (HIF-1α)在先天免疫中起着关键作用。众所周知,RSV可增强HIF-1α的表达,但RSV诱导HIF-1α表达的分子机制及其在RSV感染过程中产生先天炎性细胞因子中的作用尚不完全清楚。我们的研究表明,RSV感染在体外和体内都增加了HIF-1α的表达。对rsv诱导HIF-1α表达机制的进一步研究表明,PKCδ通过PI3K/Akt/mTOR信号通路调节rsv诱导的HIF-1α翻译。此外,在RSV感染期间,由PKCδ/PI3K/Akt/mTOR信号通路介导的HIF-1α表达通过激活nlrp3炎性小体刺激先天炎性细胞因子的产生。在体外和体内,抑制HIF-1α或PKCδ可显著抑制rsv诱导的炎症。综上所述,这些发现阐明了rsv诱导HIF-1α表达的分子机制,并确定了HIF-1α作为抗rsv药物开发的新靶点。
{"title":"HIF-1α translation mediated by PKCδ facilitates RSV-induced production of innate inflammatory cytokines in vitro and in vivo","authors":"Lifeng Chen ,&nbsp;Jiayi Chen ,&nbsp;Chuyi Liao ,&nbsp;Bin Chen ,&nbsp;Jiahua Zou ,&nbsp;Yujun Tang ,&nbsp;Si Xiong ,&nbsp;Zhong Liu ,&nbsp;Manmei Li","doi":"10.1016/j.freeradbiomed.2026.01.049","DOIUrl":"10.1016/j.freeradbiomed.2026.01.049","url":null,"abstract":"<div><div>A cytokine storm caused by respiratory syncytial virus (RSV) significantly influences the progression of pneumonia and bronchiolitis. It is essential to comprehend the underlying mechanism of the RSV-triggered cytokine storm to effectively manage RSV. Hypoxia-inducible factor-1 Alpha (HIF-1α) plays a pivotal role in innate immunity. It is known that RSV enhances HIF-1α expression, but the molecular mechanism of RSV-induced HIF-1α expression and its role in the production of innate inflammatory cytokines during RSV infection are not fully understood. Our research demonstrates that RSV infection increases HIF-1α expression both <em>in vitro</em> and <em>in vivo</em>. Further investigation into the mechanism of RSV-induced HIF-1α expression indicates that PKCδ regulates RSV-induced HIF-1α translation through the PI3K/Akt/mTOR signaling pathway. Additionally, HIF-1α expression, mediated by PKCδ/PI3K/Akt/mTOR signaling, stimulates the production of innate inflammatory cytokines by activating the NLRP3-inflammasome during RSV infection. Inhibition of HIF-1α or PKCδ markedly suppresses RSV-induced inflammation <em>in vitro</em> and <em>in vivo</em>. In summary, these findings elucidate the molecular mechanism of RSV-induced HIF-1α expression and identify HIF-1α as a novel target for anti-RSV drug development.</div></div>","PeriodicalId":12407,"journal":{"name":"Free Radical Biology and Medicine","volume":"246 ","pages":"Pages 614-626"},"PeriodicalIF":8.2,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Free Radical Biology and Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1